Lonza has acquired the Bioproducts manufacturing division of UCB for $145.6 million. UCB-Bioproducts is a chemical peptide manufacturer. This division, with approximately 300 employees, is located in Braine-l’Alleud just outside of Brussels, Belgium. The acquisition provides Lonza with another global site to serve its customer base, in addition to its sites in Switzerland, the U.S. and Czech Republic. Stefan Borgas, chief executive officer of Lonza said, “We are quite excited to...